logo
Dementia May Not Always Be the Threat It Is Now. Here's Why.

Dementia May Not Always Be the Threat It Is Now. Here's Why.

New York Times22-03-2025
Joan Presky worries about dementia. Her mother lived with Alzheimer's disease for 14 years, the last seven in a memory-care residence, and her maternal grandfather developed dementia, too.
'I'm 100 percent convinced that this is in my future,' said Ms. Presky, 70, a retired attorney in Thornton, Colo.
Last year, she spent almost a full day with a neuropsychologist, undergoing an extensive evaluation. The results indicated that her short-term memory was fine — which she found 'shocking and comforting' — and that she tested average or above in every cognitive category but one.
She's not reassured. 'I saw what Alzheimer's was like,' she said of her mother's long decline. 'The memory of what she went through is profound for me.'
The prospect of dementia, which encompasses Alzheimer's disease and a number of other cognitive disorders, so frightens Americans that a recent study projecting steep increases in cases over the next three decades drew enormous public attention.
The researchers' findings, published in January in Nature Medicine, even showed up as a joke on the Weekend Update segment of 'Saturday Night Live.'
'Dementia is a devastating condition, and it's very much related to the oldest ages,' said Dr. Josef Coresh, director of the Optimal Aging Institute at NYU Langone Health and the senior author of the study. 'The globe is getting older.'
Now the findings are being challenged by other dementia researchers who say that while increases are coming, they will be far smaller than Dr. Coresh and his co-authors predicted.
Using data from about 15,000 Americans over age 55, collected at four research clinics around the country from 1987 through 2020, Dr. Coresh's team projected a lifetime dementia risk much higher than previous studies had: 42 percent, though most of that risk didn't emerge until after age 85.
The higher lifetime number probably reflected the study's reliance on a more diverse sample than earlier researchers had used, Dr. Coresh said, and more dementia cases identified through in-depth questionnaires, regular phone calls, medical records and death certificates.
The researchers applied their risk calculations to the U.S. population and estimated that the number of people who would develop dementia each year would roughly double, to about a million by 2060, from 514,000 in 2020.
Eric Stallard, an actuary and co-director of the Biodemography of Aging Research Unit at Duke University, read the study and thought the team 'seemed very competent at their analysis' of individual risk.
But when it came to the projection that cases would double, which assumed that the incidence of dementia would remain stable over the next 40 years, 'I don't believe it,' Mr. Stallard said.
'The notion that the number of people with dementia will double over the next 25, 30 or 35 years due to the aging of baby boomers is widespread, it's pervasive — and it's wrong,' he added.
He and two other Duke researchers recently published a commentary in JAMA pointing out that the age-specific prevalence of dementia in this country had steadily declined for 40 years.
'If your risks are lower than your parents' risks and this trend continues, you won't see the doubling or tripling of dementia that's been projected,' said Dr. Murali Doraiswamy, director of the Neurocognitive Disorders Program at Duke and a co-author of the JAMA article.
To be clear, experts agree that the number of people with dementia will climb in coming decades, simply because the disorder rises so steeply with age and the number of older adults in the United States will increase.
But Mr. Stallard estimates that the increase will be more like 10 to 25 percent by 2050. 'It will still be a significant challenge for the health system in the U.S.,' he said.
The Duke group relied on its own long-term study of people over age 65, with more than 21,000 respondents in 1984 and about 16,000 in 2004, plus later data from the national Health and Retirement Study and the National Health and Aging Trends Study.
Their analysis found that among 85- to 89-year-olds, for instance, the proportion with dementia was about 23 percent in the cohort born in 1905. In those born 10 years later, the figure had dropped to about 18 percent.
By the time Americans born in 1935 reached their late 80s, about 11 percent had dementia; the projection for those born from 1945 to 1949 is now about 8 percent.
To Dr. Coresh, whose primary interest was in individual risk, the assumption that past declines would continue at about the current rate 'would be great, but is quite an optimistic, dramatic decrease,' he said in an email.
Yet in another longitudinal study of older adults in England and China, published in Nature Aging last year, 'we also found these quite marked improvements in more recently born cohorts,' said the lead author, Dr. John Beard, a medical epidemiologist at the Mailman School of Public Health at Columbia University.
'You would expect the increase in the absolute numbers of people with dementia in the U.S. will be less than we feared,' Dr. Beard said.
What has led to the decrease in dementia, also seen in several European countries? Often cited explanations include rising education levels, reduced smoking and improved treatment for high blood pressure and high cholesterol.
The Lancet Commission on dementia, intervention and care has developed a list of 14 modifiable risk factors, including greater use of hearing aids and reduced air pollution, that could still lead to greater declines.
Yet the reverse could also happen. If earlier and more widespread testing increases the number of dementia diagnoses, or if the definition of dementia broadens, rates will increase, Dr. Doraiswamy noted. Increasing life expectancy would have the same effect.
Obesity and diabetes, more common in recent decades, could lead to more dementia, but much-touted new drugs that reduce them could blunt that trend — if people can get them.
'None of this is inevitable,' said Dr. Gill Livingston, a psychiatrist at University College London who leads the Lancet Commission. 'It depends on what we do.'
Public health policy makes a major difference, she noted, and, 'The U.S. is in a time where policy is changing enormously.'
Dementia rates might rise, for example, 'if people have less access to health care, so they are less likely to get their blood pressure treated and their high cholesterol treated,' Dr. Livingston said.
Slashed Medicaid coverage could lead to that result. So could a rollback of environmental policies, 'if air pollution increases because of fossil fuels,' she added.
Already, dementia afflicts some American populations far more than others, researchers point out. Older women and Black people face greater risk, along with those who carry the APOE4 gene associated with Alzheimer's disease.
Health disparities could mean that 'affluent people will see lower rates of dementia' because of the new diabetes and obesity drugs, Dr. Doraiswamy said. 'People who can't afford them and whose conditions are not well-managed will see rates go up.'
The debate about how many older adults will develop dementia in coming decades, and about how individuals, families, government and the health care system should respond, will likely continue.
So will Ms. Presky's fears.
For now, she enrolls in lifelong learning classes, takes walks and yoga classes despite orthopedic problems, listens to podcasts and reads a lot of history and fiction. She and her husband take in theater in New York and Phish concerts on the West Coast and will soon be heading to London and Paris.
Still, her advance directive contains many provisions about dementia. 'I remain pessimistic,' she said, noting that her mother was diagnosed at 77. 'I have seven more years before I meet her fate.'
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Warren Buffett's Berkshire Hathaway reveals new stake in beleaguered insurer UnitedHealth
Warren Buffett's Berkshire Hathaway reveals new stake in beleaguered insurer UnitedHealth

NBC News

time2 minutes ago

  • NBC News

Warren Buffett's Berkshire Hathaway reveals new stake in beleaguered insurer UnitedHealth

Warren Buffett's Berkshire Hathaway revealed a new stake in troubled insurer UnitedHealth last quarter, according to a regulatory filing, a surprising buy because of the company's current reputation, but perhaps not considering his history of bargain investing. The Omaha-based conglomerate bought more than 5 million shares in the health care firm for a stake worth about $1.6 billion at the end of June. The stake puts it as the 18th biggest position in the Berkshire portfolio behind Amazon and Constellation Brands, according to VerityData. Berkshire's equity portfolio is worth about $300 billion, so it is possible that Buffett's two investing lieutenants Todd Combs and Ted Weschler were more responsible for this purchase rather than the 'Oracle of Omaha' himself. Buffett said one of his investment managers was behind the Amazon investment in 2019. The insurer's stock shot up 6% in extended trading following Berkshire's disclosure. Shares of UnitedHealth were down nearly 50% for 2025 through Thursday's close before Buffett's filing. The largest private health insurer has become the face of a public blowback in this country against the rising costs of health care. UnitedHealth is currently facing a Justice Department investigation into its Medicare billing practices. In May, the company pulled its annual earnings outlook and CEO Andrew Witty stepped down. Last month, UnitedHealth gave a new 2025 outlook that was well short of Wall Street estimates, hitting the stock further. Buffett, who's turning 95 this month, has been critical of the healthcare system in the U.S., calling it a 'tapeworm' on the economy due to its high costs. In 2018, he, along with Jeff Bezos and Jamie Dimon, launched a joint venture to improve healthcare for their employees and potentially for all Americans, but it was eventually shut down. UnitedHealth isn't the only stock Berkshire picked up recently. In fact, the conglomerate also took small stakes in steel manufacturer Nucor, outdoor advertising company Lamar Advertising and security firm Allegion. Berkshire also got back into homebuilders Lennar and DR Horton. Shares of Nucor jumped nearly 8% in afterhours trading, while Lennar and DR Horton popped about 3% each. Buffett also pared his positions in Bank of America and Apple. The Apple stake was cut by about 7%. Berkshire's largest positions as of the end of the second quarter were Apple, American Express, Bank of America, Coca-Cola and Chevron. The legendary investor is stepping down as Berkshire CEO at the end of the year, handing over the reins to Greg Abel. Buffett will stay on as chairman of the board. It's still unclear who will be in charge of Berkshire's gigantic equity portfolio, though Buffett has alluded that Abel will be making all capital allocation decisions at the conglomerate. UnitedHealth attracted other buyers last quarter, according to filings, including Michael Burry and Appaloosa Management's David Tepper. Shares of the insurer are trading at a price-earnings ratio of just under 12, near its lowest in more than a decade. There was speculation regarding a mystery stock Buffett was buying as Berkshire had asked for permission to keep certain holdings secret last quarter. It turns out the secret stock was a combination of multiple positions and likely the stakes added in DR Horton, Nucor and Lennar 'A' shares.

You can get a flu vaccine nasal spray shipped directly to your door this fall
You can get a flu vaccine nasal spray shipped directly to your door this fall

New York Post

time30 minutes ago

  • New York Post

You can get a flu vaccine nasal spray shipped directly to your door this fall

Get a whiff of this. For the first time, Americans can now skip the doctor's office and pharmacy line for their annual flu vaccine — and they can avoid needles, too. AstraZeneca's FluMist Home program officially launches today, sending nasal flu vaccines straight to people's homes. 4 The flu can cause mild to severe illness and, in some cases, lead to death. – Advertisement FluMist is a flu vaccine that's sprayed up your nose. It's been FDA-approved since 2003, and studies show it works about as well as the traditional flu shot at preventing infections and reducing the risk of serious illness. Since hitting the market more than 20 years ago, the nasal spray had only available through healthcare providers. But this season, that's changing with FluMist Home. 'This will be the first time someone will be able to give themselves a flu vaccine right in their own home,' Dr. Ravi Jhaveri, a pediatric infectious disease specialist, told The Post. 'While that may seem intimidating, this is an incredible milestone to make vaccines more accessible.' How does FluMist Home work? Advertisement The program is available in 34 states this year, with plans to expand. If it isn't offered in your state yet — like New York — you can still get the spray at your doctor's office or pharmacy. Starting today, people in eligible states can visit to complete a medical screening questionnaire, get approved and choose a delivery date. The spray will arrive in an insulated package with cooling packs to ensure it's kept at the right temperature. Liz Bodin, vice president of US respiratory and immunology, vaccines and immune therapies at AstraZeneca, told The Post that it should be used immediately after it arrives or kept in the fridge for up to two months. Advertisement 4 FluMist works by stimulating the immune system in the nose and throat, where influenza viruses typically enter the body. AstraZeneca Is it really safe to administer your own flu vaccine? To earn FDA approval, AstraZeneca conducted a study testing whether adults could successfully administer a full dose of the nasal spray — either to themselves or a child — with the provided instructions. The result? A 100% success rate. 'I'm very confident that eligible patients can administer FluMist safely and effectively at home,' Bodin said. Each shipment includes instructions with 'how-to' guides, videos, a toll-free pharmacist call center and a pharmacist chat feature. Advertisement 4 Doctors say FluMist provides a good option for needle-shy kids and adults. MediaNews Group via Getty Images Who should get a nasal flu vaccine at home? FluMist is approved for self-administration by adults ages 18 to 49, or by parents and caregivers for children between 2 and 17 years old. 'Being able to administer the vaccine in the comfort of one's own home — and to your own children — makes protection more accessible, convenient, and better aligned with the realities and current preferences of people's lives,' said Jhaveri, who also serves as a professor of pediatrics at Northwestern University. 'If your little one has a fear of needles, or your doctor's office has no appointments, or you are coordinating a complicated matrix of work, school and after-school schedules, this might be an option for you this season,' he added. 4 The FluMist Home program aims to make vaccination easier for Americans with hectic schedules who might otherwise skip the doctor's appointment. Rido – How much does it cost? Since it's part of the CDC's recommended vaccines list, most insurance plans fully cover it. There's also an $8.99 shipping fee. Prices vary for those without insurance or whose plans don't cover it, but GoodRx lists coupons can bring the cost of the nasal spray down to around $30. Advertisement Why bother with a flu shot? The 2024–2025 flu season was the worst in 15 years, with preliminary CDC data reporting at least 47 million cases, 610,000 hospitalizations and 27,000 deaths nationwide — including 216 children. At the same time, vaccinations lagged across the board. Among Americans under 18, less than half got vaccinated, down from a pre-pandemic rate of 62.4% in 2019-20. 'I strongly encourage flu vaccination — whether it's your first time or not — because it remains one of the most effective ways to prevent flu,' Jhaveri, who is also division head of infectious diseases at Chicago's Lurie Children's Hospital, said. Advertisement 'Children are especially susceptible to serious complications from the flu, such as pneumonia or hospitalization, and 150-200 children die each season — many of whom are otherwise healthy. 'My recommendation is to get your flu vaccine by the end of October, before the virus starts to circulate. It's a vital step toward protecting yourself, your family and the wellbeing of those around you.'

RealESALetter Launches Fast and Fully Online ESA Letter Service Across the US
RealESALetter Launches Fast and Fully Online ESA Letter Service Across the US

Business Upturn

time6 hours ago

  • Business Upturn

RealESALetter Launches Fast and Fully Online ESA Letter Service Across the US

By GlobeNewswire Published on August 15, 2025, 11:26 IST SURFSIDE BEACH, S.C., Aug. 15, 2025 (GLOBE NEWSWIRE) — is excited to announce its nationwide service that makes getting an emotional support animal letter easier than ever. People across America can now skip the stressful paperwork and long waits and instead get a fully legitimate ESA letter from the comfort of their home in as little as 24 hours. With more Americans relying on emotional support animals to cope with conditions like anxiety, depression, PTSD, ADHD and other emotional challenges the need for a quick and reliable ESA letter service has never been greater. RealESALetter is stepping up to meet that need with a process designed for speed simplicity and complete legal compliance. What is an ESA Letter and Why It Matters An ESA letter is an official document written by a licensed mental health professional confirming that you need an emotional support animal as part of your treatment plan. Under the Fair Housing Act this letter gives you the legal right to live with your ESA in housing that normally has no pet rules and without paying extra fees or deposits. While recent changes in federal law mean that ESAs are no longer guaranteed for airline travel they remain fully protected for housing purposes across all fifty states. This means your ESA can be with you at home providing comfort and support every day. The Four Simple Steps to Get Your ESA Letter RealESALetter has turned what used to be a complicated process into a quick and straightforward experience for anyone in the United States. Step 1: Quick Pre Screening Start by filling out a short and friendly online form to see if you might qualify. It only takes a few minutes and helps you move forward with confidence. Step 2: Choose Your Service Select the type of letter you need. Options include an ESA housing letter, a psychiatric service dog consultation or a bundle that includes both. Helpful tips guide you so you pick exactly what suits your needs. Step 3: Connect with a Licensed Professional You will be matched with a licensed mental health professional in your state. They will review your information through a secure online platform and assess your situation with care and professionalism. Step 4: Receive Your ESA Letter If approved your ESA letter will be delivered digitally to your inbox within 24 hours. For urgent needs a same day option is also available so you can get protected without delay. Why People Across United States Choose RealESALetter Fast Results : Most ESA letters are emailed to your inbox within 24 hours after approval, so you can move forward without delays. : Most ESA letters are emailed to your inbox within 24 hours after approval, so you can move forward without delays. Hard Copy Delivery : A professionally printed and signed hard copy of your ESA letter arrives at your doorstep within 3 business days. : A professionally printed and signed hard copy of your ESA letter arrives at your doorstep within 3 business days. 100% Legal Compliance : Fully compliant with all Fair Housing Act requirements and issued by licensed mental health professionals in your state. : Fully compliant with all Fair Housing Act requirements and issued by licensed mental health professionals in your state. Money-Back Guarantee : If your ESA letter is not accepted by a housing provider, you're eligible for a full refund. : If your ESA letter is not accepted by a housing provider, you're eligible for a full refund. Multi-Pet Friendly : Option to include more than one ESA in your letter at no extra hassle. : Option to include more than one ESA in your letter at no extra hassle. Nationwide Service : Licensed providers in all 50 states, ensuring your letter meets your state's legal standards. : Licensed providers in all 50 states, ensuring your letter meets your state's legal standards. Secure & Confidential : HIPAA-compliant platform that safeguards all your personal and medical information. : HIPAA-compliant platform that safeguards all your personal and medical information. Same-Day Option : For urgent cases, receive your ESA letter the same day after approval. : For urgent cases, receive your ESA letter the same day after approval. Ongoing Support: Friendly customer care team ready to assist you with renewals, landlord communications, and any questions. Protect Your Legal Rights with an ESA Letter empowers individuals to live with their emotional support animals without fear of unfair housing restrictions. Backed by the Fair Housing Act and Americans with Disabilities Act, and tailored for states with stricter rules like California, New York, and Florida, their ESA letters stand strong against legal challenges. In college dorms, suburban neighborhoods, or urban apartments with strict no-pet policies, clients gain the confidence and documentation needed to keep their ESA by their side. About RealESALetter RealESALetter is a trusted nationwide provider of legitimate ESA letters, connecting individuals with licensed mental health professionals in all fifty states in the United States. Known for speed, security, and full legal compliance, the platform has helped thousands secure housing accommodations and keep their emotional support animals by their side under the protections of the states and federal laws. With a track record of positive client reviews and a commitment to navigating even the strictest state regulations, RealESALetter continues to be a leading choice for anyone seeking reliable ESA documentation. For more information or to get started with your ESA letter today visit: Media Contact:Trina [email protected] (800) 1413 HWY 17S 1320, Surfside Beach, SC, 29575, USA Disclaimer: This press release is provided by RealESALetter. The statements, views, and opinions expressed in this content are solely those of the content provider and do not necessarily reflect the views of this media platform or its publisher. We do not endorse, verify, or guarantee the accuracy, completeness, or reliability of any information presented. This content is for informational purposes only and should not be considered financial, investment, or trading advice. Investing involves significant risks, including the potential loss of capital. Readers are strongly encouraged to conduct their own research and consult with a qualified financial advisor before making any investment decisions. Neither the media platform nor the publisher shall be held responsible for any fraudulent activities, misrepresentations, or financial losses arising from the content of this press release. In the event of any legal claims or charges against this article, we accept no liability or responsibility. Legal Disclaimer: This media platform provides the content of this article on an 'as-is' basis, without any warranties or representations of any kind, express or implied. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above. Disclaimer: The above press release comes to you under an arrangement with GlobeNewswire. Business Upturn takes no editorial responsibility for the same. Ahmedabad Plane Crash GlobeNewswire provides press release distribution services globally, with substantial operations in North America and Europe.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store